Financial Times Health– April 12, 2019. Another downside to the overuse of antibiotics is that many patients do not get the drugs they need. Most of the world’s annual 5.7m antibiotic-treatable deaths are in poorer countries. Government and industry need to work together to develop new antimicrobials. A new paper argues for economic incentives to encourage development, decoupling profits from volumes sold. (CDDEP, Stat, Science)”